Tecfidera

Chemical Namedimethyl fumarate
Dosage FormCapsule (oral; 120mg and 240mg)
Drug ClassModulators
SystemNervous
CompanyBiogen Idec
Approval Year2013

Indication

  • For the treatment of patients with relapsing forms of multiple sclerosis.
Last updated on 4/29/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Tecfidera (dimethyl fumarate) Prescribing Information2013Biogen Idec Inc., Cambridge, MA